mounjaro tirzepatid

The quick read

What's driving the attention

German courts ruled that statutory health insurance is not obliged to cover the cost of the weight loss drug Mounjaro (Tirzepatid).

Recent legal decisions in Germany have established that statutory health insurance funds (GKV) are not required to pay for the weight loss drug Mounjaro (active ingredient Tirzepatid). Although Mounjaro is available as an injectable treatment and comes in a convenient pre-filled pen form, reimbursement is contingent upon strict adherence to an approved therapy concept.